Literature DB >> 2113769

Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans.

D E Kelley1, J P Reilly, T Veneman, L J Mandarino.   

Abstract

The effects of physiological hyperinsulinemia (approximately 75 mU/l) on glucose storage, oxidation, and glycolysis in skeletal muscle were assessed with euglycemic clamps performed in seven healthy volunteers, in conjunction with leg balance for glucose, lactate, alanine, O2, and CO2. Infusion of insulin increased leg glucose uptake, storage, and oxidation but did not alter net release of lactate and alanine. The respiratory quotient (RQ) across the leg increased from a basal value of 0.74 +/- 0.02 to 0.99 +/- 0.02 during hyperinsulinemia. Under conditions of insulin stimulation, 49 +/- 5% of leg glucose uptake was stored, 37 +/- 4% was oxidized, and 14 +/- 2% was released as lactate and alanine. We conclude that during physiological hyperinsulinemia and euglycemia 1) skeletal muscle lipid oxidation is nearly entirely suppressed and glucose becomes the primary oxidative substrate of muscle, 2) glucose storage and oxidation are the major pathways of skeletal muscle glucose metabolism and are quantitatively similar at physiological insulin levels, and 3) the majority of insulin-stimulated glycolysis is oxidized, with only a small portion released as lactate or alanine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113769     DOI: 10.1152/ajpendo.1990.258.6.E923

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  40 in total

1.  Computational model of cellular metabolic dynamics: effect of insulin on glucose disposal in human skeletal muscle.

Authors:  Yanjun Li; Thomas P J Solomon; Jacob M Haus; Gerald M Saidel; Marco E Cabrera; John P Kirwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-23       Impact factor: 4.310

Review 2.  Skeletal muscle fat oxidation: timing and flexibility are everything.

Authors:  David E Kelley
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

3.  Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.

Authors:  Jason M Ng; Alessandra Bertoldo; Davneet S Minhas; Nicole L Helbling; Paul M Coen; Julie C Price; Claudio Cobelli; David E Kelley; Bret H Goodpaster
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

4.  Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.

Authors:  P M Piatti; L D Monti; S N Davis; M Conti; M D Brown; G Pozza; K G Alberti
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

5.  Energy expenditure, sex, and endogenous fuel availability in humans.

Authors:  Søren Nielsen; ZengKui Guo; Jeanine B Albu; Samuel Klein; Peter C O'Brien; Michael D Jensen
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 6.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

7.  Skeletal muscle utilization of free fatty acids in women with visceral obesity.

Authors:  S R Colberg; J A Simoneau; F L Thaete; D E Kelley
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Interaction between glucose and free fatty acid metabolism in human skeletal muscle.

Authors:  D E Kelley; M Mokan; J A Simoneau; L J Mandarino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man.

Authors:  S N Davis; L Monti; P M Piatti; M Ansiferov; C Hetherington; M Brown; H Orskov; W Branch; C N Hales; K G Alberti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 10.  Fat and carbohydrate metabolism during submaximal exercise in children.

Authors:  Julien Aucouturier; Julien S Baker; Pascale Duché
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.